Asymmetric aza-Mannich addition: Synthesis of modified chiral 2-(ethylthio)-thiazolone derivatives with anticancer potency

Organic Letters

Volumn 13, Issue 6, 2011, Pages 1494-1497

  Liu, Xiaodong ^a   Deng, Leijiao ^a   Song, Hongjin ^a   Jia, Huazhen ^a   Wang, Rui ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; CARBON; CINCHONA ALKALOID; THIAZOLE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CONFORMATION; DRUG SCREENING; HUMAN; STEREOISOMERISM; SYNTHESIS; TUMOR CELL CULTURE; X RAY CRYSTALLOGRAPHY;

AMINO ACIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBON; CATALYSIS; CINCHONA ALKALOIDS; COMBINATORIAL CHEMISTRY TECHNIQUES; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; STEREOISOMERISM; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 79952594088     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol200185h     Document Type: Article

References (60)

1. The United States Adopted Names (USAN) Council in The American Medical Association (AMA) (2005) Geometric Isomerism and Chirality: The USAN Perspective.
2. Moran, P. New Ligands for Asymmetric Hydrogenation, Specialty Chems. Magazine, July-Aug. 2003, 16.
3. For some selected general reviews on asymmetric organocatalysis, see: Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli, G. Angew. Chem., Int. Ed. 2008, 47, 6138
4. Dondoni, A.; Massi, A. Angew. Chem., Int. Ed. 2008, 47, 4638
5. Denmark, S. E.; Beutner, G. L. Angew. Chem., Int. Ed. 2008, 47, 1560
6. Dondoni, A.; Massi, A. Angew. Chem., Int. Ed. 2008, 47, 463
7. Xu, X.; Wang, W. Org. Biomol. Chem. 2008, 6, 2037
8. List, B.; Yang, J. W. Science 2006, 313, 1584
9. List, B. Chem. Commun. 2006, 819
10. Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004, 43, 5138
11. For the chiral drugs synthesis, see: Horton, D. A.; Bourne, G. T.; Smyth, M. L. Chem. Rev. 2003, 103, 893
12. Jin, Z. Nat. Prod. Rep. 2003, 20, 584
13. Frazen, R. G. J. Comb. Chem. 2000, 2, 195
14. Lewis, J. R. Nat. Prod. Rep. 1999, 16, 389
15. Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev. 1997, 97, 449
16. Thompson, L. A.; Ellman, J. A. Chem. Rev. 1996, 96, 555
17. Fruchtel, J. S.; Jung, G. Angew. Chem., Int. Ed. 1996, 35, 17
18. Zhao, H. Drug Discovery Today 2007, 12, 149
19. Biron, E.; Chatterjee, J.; Kessler, H. Org. Lett. 2006, 8, 2417
20. Deng, S.; Taunton, J. Org. Lett. 2005, 7, 299
21. Sperry, J. B.; Wright, D. L. Curr. Opin. Drug Discovery Dev. 2005, 8, 723
22. Allen, S.; Newhouse, B.; Anderson, A. S.; Fauber, B.; Allen, A.; Chantry, D.; Eberhardt, C.; Odingo, J.; Burgess, L. E. Bioorg. Med. Chem. Lett. 2004, 14, 1619
23. Böhm, H.-J.; Flohr, A.; Stahl, M. Drug Discovery Today: Technol. 2004, 1, 217
24. Wermuth, C. G. In The Practice of Medicinal Chemistry, 2 nd ed.; Academic Press: London, 2003; p 193.
25. Barreca, M. L.; Balzarini, J.; Chimirri, A.; Clercq, E. D.; Luca, L. D.; Höltje, H. D.; Höltje, M.; Monforte, A. M.; Monforte, P.; Pannecouque, C.; Rao, A.; Zappalà, M. J. Med. Chem. 2002, 45, 5410
26. Siddiqui, I. R.; Singh, P. K.; Singh, J.; Singh, J. J. Agric. Food Chem. 2003, 51, 7062
27. Kenderekar, P. S.; Siddiqui, R. F.; Patil, P. S.; Bhusare, S. R.; Pawar, R. P. Ind. J. Pharm. Sci. 2003, 65, 313
28. Galietta, J. V.; Verkman, A. S. J. Biol. Chem. 2002, 277, 29224
29. Rzasa, R. M.; Shea, H. A.; Romo, D. J. Am. Chem. Soc. 1998, 120, 591
30. Mulzer, J.; Mantoulider, A.; Ohler, E. Tetrahedron Lett. 1997, 38, 7725
31. Badorc, A.; Bordes, M. F.; DeCointel, P.; Savi, P.; Lale, A.; Petitou, M.; Maffrand, J. P.; Herbert, J. M. J. Med. Chem. 1997, 40, 3393
32. Reddy, K. H.; Reddy, P. S.; Babu, P. R. J. Inorg. Biochem. 1999, 77, 169
33. Perez, J. M.; Matesanz, A. I.; Marin-Ambite, A.; Navarro, P.; Alonso, C.; Souza, P. J. Inorg. Biochem. 1999, 75, 255
34. Hall, I. H.; Cheen, S. Y.; Barnes, B. J.; Wext, X. D. Met. Based Drugs 1999, 6, 143-147
35. Uraguchi, D.; Koshimoto, K.; Ooi, T. Chem. Commun. 2010, 46, 300 For racemic ones, see: Havrylyuk, D.; Zimenkovsky, B.; Vasylenko, O.; Zaprutko, L.; Gzella, A.; Lesyk, R. Eur. J. Med. Chem. 2009, 4, 1396
36. Khan, S. A.; Yusuf, M. Eur. J. Med. Chem. 2009, 44, 2597
37. Verma, A.; Saraf, S. K. Eur. J. Med. Chem. 2008, 43, 897
38. Qiao, Q.; Dominique, R.; Goodnow, R., Jr. Tetrahedron Lett. 2008, 49, 3682
39. Thompson, M. J.; Heal, W.; Chen, B. Tetrahedron Lett. 2006, 47, 2361
40. Boy, K. M.; Guernon, J. M. Tetrahedron Lett. 2005, 46, 2251
41. Ochiai, M.; Nishi, Y.; Hashimoto, S.; Tsuchimoto, Y.; Chen, D.-W. J. Org. Chem. 2003, 68, 7887
42. Suzuki, M.; Morita, K.; Yukioka, H.; Miki, N.; Mizutani, A. J. Pesticide Sci. 2003, 28, 37
43. Hodgetts, K. J.; Kershaw, M. T. Org. Lett. 2002, 4, 1363
44. Marcantonio, K. M.; Frey, F. L.; Murry, J. A.; Chen, C.-Y. Tetrahedron Lett. 2002, 43, 8845
45. Qiao, Q.; So, S.-S.; Goodnow, R. A., Jr. Org. Lett. 2001, 3, 3655
46. Lin, Y. H.; Andersen, K. K. Eur. J. Org. Chem. 2002, 557
47. For reviews on chiral cinchona alkaloid catalysts, see: Connon, S. J. Chem. Commun. 2008, 2499
48. Marcelli, T.; van Maarseveen, J. H.; Hiemstra, H. Angew. Chem., Int. Ed. 2006, 45, 7496
49. Tian, S.-K.; Chen, Y. G.; Hang, J. F.; Tang, L.; McDaid, P.; Deng, L. Acc. Chem. Res. 2004, 37, 621
50. Chen, Y. G.; McDaid, P.; Deng, L. Chem. Rev. 2003, 103, 2965 For selected examples of chiral cinchona alkaloid catalysis, see: Liu, Y.; Sun, B. F.; Wang, B. M.; Wakem, M.; Deng, L. J. Am. Chem. Soc. 2009, 131, 41
51. Dodda, R.; Goldman, J. J.; Mandal, T.; Zhao, C.-G.; Broker, G. A.; Tiekink, E. R. T. Adv. Synth. Catal. 2008, 350, 537
52. Liu, T.-Y.; Cui, H.-L.; Chai, Q.; Long, J.; Li, B. J.; Wu, Y.; Ding, L.-S.; Chen, Y.-C. Chem. Commun. 2007, 2228
53. Comer, E.; Rohan, E.; Deng, L., Jr.; Porco, J. A. Org. Lett. 2007, 9, 2123
54. Wang, J.; Li, H.; Zu, L.; Jiang, W.; Xie, H.; Duan, W.; Wang, W. J. Am. Chem. Soc. 2006, 128, 12652
55. Saaby, S.; Bella, M.; Jørgensen, K. A. J. Am. Chem. Soc. 2004, 126, 8120
56. Yoon, T. P.; Jacobsen, E. N. Science 2003, 299, 1691 For chiral cinchona alkaloid catalysis in our group recently, see: Sun, W. S.; Hong, L.; Liu, C. X.; Wang, R. Org. Lett. 2010, 12, 3914
57. Liu, X. D.; Deng, L. J.; Jiang, X. X.; Yan, W. J.; Liu, C. L.; Wang, R. Org. Lett. 2010, 12, 876
58. Under the optimized conditions, the alkyl-substituted isobutyl N -tosyl imine showed no reactivity toward 2-(ethylthio)-thiazolone 2a.
59. CCDC 800993 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/daa-request/cif.
60. The dose-dependent growth inhibition ability was shown in the Supporting Information.